TNBC is considered the most immunogenic subtype, with higher levels of tumor-infiltrating lymphocytes (TILs), programmed cell death-ligand 1 (PD-L1) expression, and tumor mutation burden (TMB) compared to other subtypes. The gene discussed is CD274; the disease is neoplasm.